Bronchiectasis is a chronic lung condition characterized by irreversible widening and thickening of the bronchial tubes, leading to a buildup of mucus and recurrent infections. This condition impairs the lungs' ability to clear mucus effectively, resulting in symptoms such as chronic cough, excessive sputum production, and recurrent respiratory infections. Treatment aims to manage symptoms, clear airway secretions, prevent complications, and improve quality of life through medications, airway clearance techniques, pulmonary rehabilitation, and, in some cases, surgery.
Patients are the experts in their condition and advocacy groups provide a platform for patient voices. Working directly with these communities is the key to pushing research forward in an inclusive way.
We’ve committed to having 500,000 conversations in the next three years, to equip ourselves and our Pharma partners with the insights needed to increase predictability.
Read more...
The ever-growing investment in advocacy doesn’t appear to be slowing down, and research is certainly seeing the benefits. Which at the end of the day, means better patient care and more options for patients.
Read more...
We’re ready to keep forming links between our Advocacy friends and Pharma partners, so these fruitful relationships continue to evolve beyond the study-to-study view.
Read more...
Bronchiectasis is a prevalent but often misunderstood respiratory condition. Understanding the causes, symptoms, and potential treatments for bronchiectasis is essential for raising awareness and improving the quality of life for patients. At Leapcure, we're here to support patients and advocates. Our platform provides information and links to support groups for bronchiectasis patients.
Read more...